Literature DB >> 18721135

Increased glucose metabolism and ATP level in brain tissue of Huntington's disease transgenic mice.

Judit Oláh1, Péter Klivényi, Gabriella Gardián, László Vécsei, Ferenc Orosz, Gabor G Kovacs, Hans V Westerhoff, Judit Ovádi.   

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder characterized by multifarious dysfunctional alterations including mitochondrial impairment. In the present study, the formation of inclusions caused by the mutation of huntingtin protein and its relationship with changes in energy metabolism and with pathological alterations were investigated both in transgenic and 3-nitropropionic acid-treated mouse models for HD. The HD and normal mice were characterized clinically; the affected brain regions were identified by immunohistochemistry and used for biochemical analysis of the ATP-producing systems in the cytosolic and the mitochondrial compartments. In both HD models, the activities of some glycolytic enzymes were somewhat higher. By contrast, the activity of glyceraldehyde-3-phosphate dehydrogenase was much lower in the affected region of the brain compared to that of the control. Paradoxically, at the system level, glucose conversion into lactate was enhanced in cytosolic extracts from the HD brain tissue, and the level of ATP was higher in the tissue itself. The paradox could be resolved by taking all the observed changes in glycolytic enzymes into account, ensuing an experiment-based detailed mathematical model of the glycolytic pathway. The mathematical modelling using the experimentally determined kinetic parameters of the individual enzymes and the well-established rate equations predicted the measured flux and concentrations in the case of the control. The same mathematical model with the experimentally determined altered V(max) values of the enzymes did account for an increase of glycolytic flux in the HD sample, although the extent of the increase was not predicted quantitatively. This suggested a somewhat altered regulation of this major metabolic pathway in HD tissue. We then used the mathematical model to develop a hypothesis for a new regulatory interaction that might account for the observed changes; in HD, glyceraldehyde-3-phosphate dehydrogenase may be in closer proximity (perhaps because of the binding of glyceraldehyde-3-phosphate dehydrogenase to huntingtin) with aldolase and engage in channelling for glyceraldehyde-3-phosphate. By contrast to most of the speculation in the literature, our results suggest that the neuronal damage in HD tissue may be associated with increased energy metabolism at the tissue level leading to modified levels of various intermediary metabolites with pathological consequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721135     DOI: 10.1111/j.1742-4658.2008.06612.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  29 in total

Review 1.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

2.  Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice.

Authors:  Aris A Polyzos; Do Yup Lee; Rupsa Datta; Meghan Hauser; Helen Budworth; Amy Holt; Stephanie Mihalik; Pike Goldschmidt; Ken Frankel; Kelly Trego; Michael J Bennett; Jerry Vockley; Ke Xu; Enrico Gratton; Cynthia T McMurray
Journal:  Cell Metab       Date:  2019-03-28       Impact factor: 27.287

Review 3.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

4.  Oxidative metabolism in YAC128 mouse model of Huntington's disease.

Authors:  James Hamilton; Jessica J Pellman; Tatiana Brustovetsky; Robert A Harris; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2015-06-03       Impact factor: 6.150

Review 5.  Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling.

Authors:  Nickolay Brustovetsky
Journal:  Mol Neurobiol       Date:  2015-05-05       Impact factor: 5.590

6.  Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease.

Authors:  Ivan Tkac; Pierre-Gilles Henry; Lori Zacharoff; Michael Wedel; Wuming Gong; Dinesh K Deelchand; Tongbin Li; Janet M Dubinsky
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-18       Impact factor: 6.200

7.  Oxidative metabolism and Ca2+ handling in striatal mitochondria from YAC128 mice, a model of Huntington's disease.

Authors:  James Hamilton; Tatiana Brustovetsky; Nickolay Brustovetsky
Journal:  Neurochem Int       Date:  2017-01-03       Impact factor: 3.921

8.  Mutant huntingtin does not cross the mitochondrial outer membrane.

Authors:  James Hamilton; Tatiana Brustovetsky; Rajesh Khanna; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

9.  Early alterations of brain cellular energy homeostasis in Huntington disease models.

Authors:  Fanny Mochel; Brandon Durant; Xingli Meng; James O'Callaghan; Hua Yu; Emmanuel Brouillet; Vanessa C Wheeler; Sandrine Humbert; Raphael Schiffmann; Alexandra Durr
Journal:  J Biol Chem       Date:  2011-11-28       Impact factor: 5.157

10.  Oxidative metabolism and Ca2+ handling in isolated brain mitochondria and striatal neurons from R6/2 mice, a model of Huntington's disease.

Authors:  James Hamilton; Jessica J Pellman; Tatiana Brustovetsky; Robert A Harris; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2016-04-30       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.